Neil Torpey is a partner in the Corporate Department of Paul Hastings. His practice focuses on mergers and acquisitions, private equity and venture capital, and capital markets matters. He serves as chair of our Hong Kong office and also is resident in our New York office, and has served as vice-chair of our global Corporate Department and as a member of our Policy Committee, our Recruiting Committee and our Partnership Evaluation Committee.
Mr. Torpey has extensive experience in the representation of public and private business organizations in connection with public and private mergers and acquisitions, leveraged buyouts, securities offerings, and private equity and venture capital transactions; the representation of sponsors and investors in connection with the establishment of private equity funds; the representation of investment banks and issuers in capital markets transactions; and the representation of companies as general counsel in connection with a variety of corporate and commercial matters. He has had extensive experience structuring and executing transactions in the U.S., Asia, Latin America and Europe.
Accolades and Recognitions
Consistently listed as a leading lawyer in Chambers Asia and in Asia Pacific Legal 500
Cornell Law School, J.D., 1985
Colgate University, B.A., 1982 (cum laude )
Member, Board of Directors, BOCI-Prudential Trustee Limited (a joint venture of The Bank of China and Prudential)
Member, Board of Directors, Colgate University Alumni Corporation
Member, Board of Directors, Friends of Kellett School
Member, Hong Kong Institute of Chartered Secretaries -- Technical Consultation Panel
Prior experience includes service as a member of the staff of United States Senator Bill Bradley and of the United States Federal Reserve Board
Advisor, Cornell Law School Tech LLM Program
Adjunct Professor, Cornell Tech Program
China Bohai Bank, a nationwide joint-stock commercial bank in China, on its US$1.77 billion global offering and listing of its H Shares on the Main Board of the Hong Kong Stock Exchange. CCB International, Haitong International, ABCI Capital and CLSA acted as the joint sponsors.
Credit Suisse, Morgan Stanley, and ICBC International Capital as joint sponsors in the US$381 million global initial public offering and listing on the Main Board of The Hong Kong Stock Exchange of JS Global Lifestyle, a Chinese small appliance manufacturer which is a portfolio company of leading PRC-based private equity investor CDH Investments.
Represented Novacap Technologies III, L.P., an international private equity fund, in connection with the acquisition of Oxford Networks, Inc., a diversified telecommunications and data center services provider, and related debt financing.
Represented Novacap Technologies III, L.P. and Novacap Technologies IV, L.P. in connection with the acquisition of Utel Inc./Freedom Ring Communications, LLC, a telecommunications and fiber network services provider, and related debt financing.
Represented Novacap Technologies III, L.P., and Novacap Technologies IV, L.P. in connection with the sale of Oxford Networks, Inc. to affiliates of Oak Hill Capital Partners.
Representing Novacap Technologies V, L.P., and affiliated fund investors, in connection with the acquisition of Horizon Telcom, Inc., a telecommunications and fiber network services provider, and related debt financing.
Represented Ayala Corporation in connection with the transfer of its general partner and management company interests in Arch Capital Asian Partners, G.P. and Arch Capital Management Co. Limited, a real estate private equity investor, to The Rohatyn Group.
Represented a global real estate private equity firm in the establishment of several Asia-focused real estate private equity funds involving over $2.0 billion in capital commitments.
Represented consortia of private equity and strategic investors in connection with acquisitions of data center businesses in the U.S., Europe, Asia and Latin America.
Represented Morgan Stanley, UBS, and Bank of America Merrill Lynch, as well as numerous issuers, respectively, in global equity offerings including Hong Kong IPOs and Rule 144A/Reg S offerings.
Represented Caladrius Biosciences, Inc., a vertically-integrated, clinical-stage biopharmaceutical therapeutics company (NASDAQ: CLBS), in connection with various public and private equity offerings and strategic transactions.
Represented Shanghai Electric (Group) Corporation, a large Chinese state-owned-enterprise, and certain of its affiliates, in connection with the restructuring of Goss International Corporation, a global manufacturer of industrial printing equipment and related products and services, and the sale of Goss International Corporation to affiliates of American Industrial Partners, a New York-based private equity firm.
Represented CDH Investments and affiliated investors in connection with the acquisition of Euro-Pro Holdco, LLC, parent of entities manufacturing and distributing SharkNinja consumer products, and related commercial joint ventures in China.